First Personal Financial Services’s Supernus Pharmaceuticals SUPN Stock Holding History

First Personal Financial Services’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-108	Closed	-$4K	–	732
2019 Q2	$4K	Hold	108	–	–	﹤0.01%	619
2019 Q1	$4K	Hold	108	–	–	﹤0.01%	625
2018 Q4	$4K	Hold	108	–	–	﹤0.01%	590
2018 Q3	$5K	Hold	108	–	–	﹤0.01%	605
2018 Q2	$6K	Sell	108 -145	-57%	-$7.51K	﹤0.01%	558
2018 Q1	$12K	Sell	253 -2	-0.8%	-$83	﹤0.01%	746
2017 Q4	$10K	Buy	255 +86	+51%	+$3.4K	﹤0.01%	784
2017 Q3	$7K	Sell	169 -184	-52%	-$7.96K	﹤0.01%	755
2017 Q2	$15K	Buy	353 +38	+12%	+$1.35K	﹤0.01%	635
2017 Q1	$10K	Sell	315 -40	-11%	-$1.07K	﹤0.01%	714
2016 Q4	$9K	Sell	355 -136	-28%	-$3.04K	﹤0.01%	735
2016 Q3	$12K	Sell	491 -97	-16%	-$2.19K	﹤0.01%	543
2016 Q2	$12K	Buy	+588	New	+$10.4K	﹤0.01%	531

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

ACM

Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return

First Personal Financial Services's SUPN Position: Q3 2019 in Review

First Personal Financial Services sold out of Supernus Pharmaceuticals (SUPN) in Q3 2019, closing a stake of 108 shares — an estimated $4K sold.

First Personal Financial Services first reported a position in SUPN in Q2 2016 and held it in 13 quarters. The position peaked at $15K in Q2 2017. 243 funds tracked by Wall St. Rank hold SUPN as of Q3 2019.

First Personal Financial Services reported no remaining Supernus Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
First Personal Financial Services sold 108 Supernus Pharmaceuticals shares in Q3 2019, an estimated $4K.
First Personal Financial Services first reported a position in Supernus Pharmaceuticals in Q2 2016 and held it in 13 quarters.
First Personal Financial Services's Supernus Pharmaceuticals position peaked at $15K in Q2 2017.
243 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2019.

Based on First Personal Financial Services's 13F filing for Q3 2019, filed 15 Oct 2019.